Remove Compounding Remove Vaccines Remove Webinar
article thumbnail

Meet Mickey O’Connor, Epicur Pharma’s Director of Business Development

epicur

My first job here with Stokes was as a sales rep selling human compounded medication. There’s still a lack of understanding of the difference between a 503A traditional compounding pharmacy versus a 503B outsourcing facility. Going into compounding was challenging because compounding is different than traditional retail.

article thumbnail

Immuno-oncology market set to grow in billions, but access concerns remain

Pharmaceutical Technology

While the market was worth over $6 billion in 2012, this has now grown to nearly $48 billion only a decade later, said Avigayil Chalk, PhD, GlobalData’s Senior Oncology and Haematology analyst, at an immuno-oncology webinar held on May 23. This high compound annual growth rate of 23.6%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Quality first: How pharma can meet injectables demand while staying compliant

Pharmaceutical Technology

During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry. While production volumes have now fallen, future vaccine demand is hard to predict, as booster shots could be needed at any point to control emerging variants.

article thumbnail

The Shelter’s Place in Veterinary Medicine: Personal Insights with Allyne Moon, Shelter Consultant

epicur

We can set up free or low-cost vaccine clinics in “veterinary deserts.” There’s not a lot of veterinary care available for people in the community, and we can get their pets vaccinated and administer flea preventatives and other parasiticides. I can always rely on my compounders to get me something close that I can use.